Articles

  • Dec 8, 2024 | yahoo.com | Deborah Cohen

    It is among the most delicate and controversial challenges in modern medicine - how to determine whether the benefits of puberty blockers (or drugs that delay puberty) outweigh the potential harms. This question came to the fore in June 2023 when NHS England proposed that in the future, these drugs would only be prescribed to children questioning their gender as part of clinical research.

  • Sep 5, 2024 | healthaffairs.org | Kevin Grumbach |Deborah Cohen |Yalda Jabbarpour

    If you thought for-profit conglomerates were going to save primary care, maybe it is time to think again. National primary care scorecards document the increasingly imperiled state of primary care in the US, the result of decades of underinvestment. Calls for bold policy reforms to increase primary care payment and investment in practice infrastructure have failed to reverse the decline.

  • Jan 12, 2024 | bmj.com | Deborah Cohen |Margaret McCartney

    Deborah Cohen, freelance journalist1, Margaret McCartney, GP21London2GlasgowThe government’s policy to fast track “innovative” drugs into the NHS to showcase the UK as a great place for industry has been described as “a pretty spectacular failure,” because of the way a test case using the cholesterol lowering drug inclisiran was received.

  • Dec 13, 2023 | newyorkfolk.com | James White |Deborah Cohen

    This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. American legislators demand scenarios for war termination that neither Ukraine nor the Biden administration can provide, because critics of Ukraine aid are asking the wrong questions.

  • Dec 13, 2023 | newsbreak.com | Deborah Cohen

    I BM is one of the oldest technology companies in the world, with a raft of innovations to its credit, including mainframe computing, computer-programming languages, and AI-powered tools. But ask an ordinary person under the age of 40 what exactly IBM does (or did), and the responses will be vague at best. “Something to do with computers, right?” was the best the Gen Zers I queried could come up with.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →